Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
NeoGrid, a Chicago-based provider of supply chain management solutions, partnered with the Brazilian startup Lett Insights to expand its offering of supply chain services.
Americans spent 7 percent more money on prescription drugs in 2016 than in 2015, presenting the largest increase since 1992, according to a report from the Bureau of Labor Statistics.
Johnson & Johnson Innovation will open a facility dedicated to expediting the development of "breakthrough" medical devices at Houston-based Texas Medical Center.
The Food and Drug Administration approved Roche's bladder cancer drug Tecentriq as a second-line treatment for patients with metastatic non-small cell lung cancer.
Bartlett (Tenn.) High School recently opened a Machine Tool Tech Lab on campus where students can learn how to use machinery to make medical devices, reports The Commercial Appeal.
Sen. Richard Blumenthal (D-Conn.) sent a letter to the Department of Justice Monday, urging the entity to reject a recent settlement with Canonsburg, Pa.-based drugmaker Mylan.
TPC — a network of independent healthcare providers and regional purchasing coalition based in Plano, Texas — will partner with Resource Optimization & Innovation, a provider-owned group purchasing organization based in St. Louis.
When searching for savings opportunities, it is wise to sort your item master file using the Pareto principle, also known as the 80/20 rule, says John Mateka, MBA, MHA, interim director of materials management for Florence, S.C.-based McLeod Health.
New York City-based Pfizer will start shipping its biosimilar copy of Johnson & Johnson's best-selling arthritis drug Remicade in November, offering the drug at a 15 percent discount, according to Reuters.
Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to Japan-based Terumo for about $1.1 billion, reports Reuters.